The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The Global Burden of Cancer 2013
Open accessAbstract
IMPORTANCE: Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies. OBJECTIVE: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex from 1990 to 2013. EVIDENCE REVIEW: The general methodology of the Global Burden of Disease (GBD) 2013 study was used. Cancer registries were the source for cancer incidence data as well as mortality incidence (MI) ratios. Sources for cause of death data include vital registration system data, verbal autopsy studies, and other sources. The MI ratios were used to transform incidence data to mortality estimates and cause of death estimates to incidence estimates. Cancer prevalence was estimated using MI ratios as surrogates for survival data; YLDs were calculated by multiplying prevalence estimates with disability weights, which were derived from population-based surveys; YLLs were computed by multiplying the number of estimated cancer deaths at each age with a reference life expectancy; and DALYs were calculated as the sum of YLDs and YLLs. FINDINGS: In 2013 there were 14.9 million incident cancer cases, 8.2 million deaths, and 196.3 million DALYs. Prostate cancer was the leading cause for cancer incidence (1.4 million) for men and breast cancer for women (1.8 million). Tracheal, bronchus, and lung (TBL) cancer was the leading cause for cancer death in men and women, with 1.6 million deaths. For men, TBL cancer was the leading cause of DALYs (24.9 million). For women, breast cancer was the leading cause of DALYs (13.1 million). Age-standardized incidence rates (ASIRs) per 100 000 and age-standardized death rates (ASDRs) per 100 000 for both sexes in 2013 were higher in developing vs developed countries for stomach cancer (ASIR, 17 vs 14; ASDR, 15 vs 11), liver cancer (ASIR, 15 vs 7; ASDR, 16 vs 7), esophageal cancer (ASIR, 9 vs 4; ASDR, 9 vs 4), cervical cancer (ASIR, 8 vs 5; ASDR, 4 vs 2), lip and oral cavity cancer (ASIR, 7 vs 6; ASDR, 2 vs 2), and nasopharyngeal cancer (ASIR, 1.5 vs 0.4; ASDR, 1.2 vs 0.3). Between 1990 and 2013, ASIRs for all cancers combined (except nonmelanoma skin cancer and Kaposi sarcoma) increased by more than 10% in 113 countries and decreased by more than 10% in 12 of 188 countries. CONCLUSIONS AND RELEVANCE: Cancer poses a major threat to public health worldwide, and incidence rates have increased in most countries since 1990. The trend is a particular threat to developing nations with health systems that are ill-equipped to deal with complex and expensive cancer treatments. The annual update on the Global Burden of Cancer will provide all stakeholders with timely estimates to guide policy efforts in cancer prevention, screening, treatment, and palliation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citationNg, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationMurray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Self-citationCancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citationSpencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Self-citationCancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043 · cited 2×
“The GBD provides a unique source for data on cancer for 3 reasons: (1) a standardized statistical framework has been used to analyze both cancer registry data and cause of death data by country and over time; (2) in addition to incidence and mortality, other metrics such as DALYs have been used to quantify health loss…”
BackgroundMethodSelected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Self-citationHEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B., Wollum, A., Sanman, E., Wulf, S., Lopez, A. D., et al. (2014) · JAMA · doi:10.1001/jama.2013.284692 · Cited by 1,576
Salomon, J. A., Vos, T., Hogan, D. R., Gagnon, M., Naghavi, M., Mokdad, A., Begum, N., Shah, R., Karyana, M., Kosen, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61680-8 · Cited by 1,322
Self-citationKorea's Thyroid-Cancer “Epidemic” — Screening and Overdiagnosis
Ahn, H. S., Kim, H. J., & Welch, H. G. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1409841 · Cited by 1,236
Edwards, B. K., Noone, A., Mariotto, A. B., Simard, E. P., Boscoe, F. P., Henley, S. J., Jemal, A., Cho, H., Anderson, R. N., Kohler, B. A., et al. (2014) · Cancer · doi:10.1002/cncr.28509 · Cited by 1,210
Self-citationRisk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282501 · Cited by 1,126
Salomon, J. A., Wang, H., Freeman, M. K., Vos, T., Flaxman, A. D., Lopez, A. D., & Murray, C. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61690-0 · Cited by 1,116
GBD 2010: design, definitions, and metrics
Murray, C. J., Ezzati, M., Flaxman, A. D., Lim, S., Lozano, R., Michaud, C., Naghavi, M., Salomon, J. A., Shibuya, K., Vos, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61899-6 · Cited by 1,103
Self-citationWang, H., Dwyer-Lindgren, L., Lofgren, K. T., Rajaratnam, J. K., Marcus, J. R., Levin-Rector, A., Levitz, C. E., Lopez, A. D., & Murray, C. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61719-x · Cited by 810
Wang, H., Liddell, C. A., Coates, M. M., Mooney, M. D., Levitz, C. E., Schumacher, A. E., Apfel, H., Iannarone, M., Phillips, B., Lofgren, K. T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60497-9 · Cited by 799
Self-citationInequalities in non-communicable diseases and effective responses
Di Cesare, M., Khang, Y.-H., Asaria, P., Blakely, T., Cowan, M. J., Farzadfar, F., Guerrero, R., Ikeda, N., Kyobutungi, C., Msyamboza, K. P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61851-0 · Cited by 678
Obesity, Hypertension, and the Risk of Kidney Cancer in Men
Chow, W.-H., Gridley, G., Fraumeni, J. F., & Järvholm, B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431804 · Cited by 668
Yuen, M.-F., Tanaka, Y., Fong, D. Y.-T., Fung, J., Wong, D. K.-H., Yuen, J. C.-H., But, D. Y.-K., Chan, A. O.-O., Wong, B. C.-Y., Mizokami, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.023 · Cited by 584
Modeling causes of death: an integrated approach using CODEm
Foreman, K. J., Lozano, R., Lopez, A. D., & Murray, C. J. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-1 · Cited by 564
Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness
Parkin, D. M., & Bray, F. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.033 · Cited by 536
Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies
Hunt, J. D., van der Hel, O. L., McMillan, G. P., Boffetta, P., & Brennan, P. (2005) · International Journal of Cancer · doi:10.1002/ijc.20618 · Cited by 525
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El–Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.020 · Cited by 501
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
Coleman, M. P., Gatta, G., Verdecchia, A., Estève, J., Sant, M., Storm, H., Allemani, C., Ciccolallo, L., Santaquilani, M., & Berrino, F. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg756 · Cited by 483
Chen, C.-J., Liang, K.-Y., Chang, A.-S., Chang, Y.-C., Lu, S.-N., Liaw, Y.-F., Chang, W.-Y., Sheen, M.-C., & Lin, T.-M. (1991) · Hepatology · doi:10.1002/hep.1840130303 · Cited by 247
Accuracy of visual inspection with acetic acid for cervical cancer screening
Sauvaget, C., Fayette, J., Muwonge, R., Wesley, R., & Sankaranarayanan, R. (2011) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.10.012 · Cited by 245
Yu, I. T. S., Chiu, Y.-L., Au, J. S. K., Wong, T.-W., & Tang, J.-L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2932 · Cited by 244
Sankaranarayanan, R., Nene, B. M., Dinshaw, K. A., Mahe, C., Jayant, K., Shastri, S. S., Malvi, S. G., Chinoy, R., Kelkar, R., Budukh, A. M., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21050 · Cited by 233
Tobacco use in sub-Sahara Africa: Estimates from the demographic health surveys
Pampel, F. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2007.12.003 · Cited by 218
International renal‐cell cancer study. IV. Occupation
Mandel, J. S., McLaughlin, J. K., Schlehofer, B., Mellemgaard, A., Helmert, U., Lindblad, P., McCredie, M., & Adami, H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610503 · Cited by 200
Cancer incidence, survival and mortality: Explaining the concepts
Ellis, L., Woods, L. M., Estève, J., Eloranta, S., Coleman, M. P., & Rachet, B. (2014) · International Journal of Cancer · doi:10.1002/ijc.28990 · Cited by 161
Sankaranarayanan, R., Anorlu, R. I., Sangwa‐Lugoma, G., & Denny, L. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.06.066 · Cited by 110
Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa
Campos, N. G., Kim, J. J., Castle, P. E., Ortendahl, J. D., O'Shea, M. K. H., Díaz, M., & Goldie, S. J. (2011) · International Journal of Cancer · doi:10.1002/ijc.26269 · Cited by 98
Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates
Ho, A. S., Davies, L., Nixon, I. J., Palmer, F. L., Wang, L. Y., Patel, S. G., Ganly, I., Wong, R. J., Tuttle, R. M., & Morris, L. G. T. (2015) · Cancer · doi:10.1002/cncr.29289 · Cited by 89
Initial results from a randomized trial of cervical visual screening in rural south India
Sankaranarayanan, R., Rajkumar, R., Theresa, R., Esmy, P. O., Mahe, C., Bagyalakshmi, K. R., Thara, S., Frappart, L., Lucas, E., Muwonge, R., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.11726 · Cited by 88
Underreporting of Myeloid Malignancies by United States Cancer Registries
Craig, B. M., Rollison, D. E. M., List, A. F., & Cogle, C. R. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1087 · Cited by 76
Prospective Evaluation of Analgesic Use and Risk of Renal Cell Cancer
Cho, E. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.356 · Cited by 74
The roles of smoking and cooking emissions in lung cancer risk among Chinese women in Hong Kong
Wang, X.-R., Chiu, Y.-L., Qiu, H., Au, J. S. K., & Yu, I. T.-S. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn699 · Cited by 74
Pandeya, N., McLeod, D. S. A., Balasubramaniam, K., Baade, P. D., Youl, P., Bain, C., Allison, R., & Jordan, S. J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12724 · Cited by 71
Yin, Z., Cui, Z., Ren, Y., Zhang, H., Yan, Y., Zhao, Y., Ma, R., Wang, Q., He, Q., & Zhou, B. (2014) · Medical Oncology · doi:10.1007/s12032-014-0114-5 · Cited by 39
Pancreatic cancer; reporting and long-term survival in Sweden
Lambe, M. P., Eloranta, S., Wigertz, A., & Blomqvist, P. (2011) · Acta Oncologica · doi:10.3109/0284186x.2011.599338 · Cited by 38
Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers
Kilander, C., Mattsson, F., Ljung, R., Lagergren, J., & Sadr‐Azodi, O. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.857429 · Cited by 37
Cited by
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,215
Self-citationGlobal Burden of Disease Cancer Collaboration, Fitzmaurice, C., Abate, D., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdel-Rahman, O., Abdelalim, A., Abdoli, A., Abdollahpour, I., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.2996 · Cited by 2,501
Self-citationHsieh, J. J., Purdue, M. P., Signoretti, S., Swanton, C., Albiges, L., Schmidinger, M., Heng, D. Y., Larkin, J., & Ficarra, V. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.9 · Cited by 2,426
Global Burden of Disease 2019 Cancer Collaboration, Kocarnik, J. M., Compton, K., Dean, F. E., Fu, W., Gaw, B. L., Harvey, J. D., Henrikson, H. J., Lu, D., Pennini, A., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2021.6987 · Cited by 2,026
Self-citationGlobal Epidemiology of Lung Cancer
Barta, J. A., Powell, C. A., & Wisnivesky, J. P. (2019) · Annals of Global Health · doi:10.5334/aogh.2419 · Cited by 1,575
Metadata
- Authors
- Fitzmaurice, C., Dicker, D., Pain, A., Hamavid, H., Moradi-Lakeh, M., MacIntyre, M. F., Allen, C., Hansen, G., Woodbrook, R., Wolfe, C., Hamadeh, R. R., Moore, A., Werdecker, A., Gessner, B. D., Te Ao, B., McMahon, B., Karimkhani, C., Yu, C., Cooke, G. S., Schwebel, D. C., Carpenter, D. O., Pereira, D. M., Nash, D., Kazi, D. S., De Leo, D., Plass, D., Ukwaja, K. N., Thurston, G. D., Yun Jin, K., Simard, E. P., Mills, E., Park, E.-K., Catalá-López, F., deVeber, G., Gotay, C., Khan, G., Hosgood, H. D., Santos, I. S., Leasher, J. L., Singh, J., Leigh, J., Jonas, J. B., Sanabria, J., Beardsley, J., Jacobsen, K. H., Takahashi, K., Franklin, R. C., Ronfani, L., Montico, M., Naldi, L., Tonelli, M., Geleijnse, J., Petzold, M., Shrime, M. G., Younis, M., Yonemoto, N., Breitborde, N., Yip, P., Pourmalek, F., Lotufo, P. A., Esteghamati, A., Hankey, G. J., Ali, R., Lunevicius, R., Malekzadeh, R., Dellavalle, R., Weintraub, R., Lucas, R., Hay, R., Rojas-Rueda, D., Westerman, R., Sepanlou, S. G., Nolte, S., Patten, S., Weichenthal, S., Abera, S. F., Fereshtehnejad, S.-M., Shiue, I., Driscoll, T., Vasankari, T., Alsharif, U., Rahimi-Movaghar, V., Vlassov, V. V., Marcenes, W. S., Mekonnen, W., Melaku, Y. A., Yano, Y., Artaman, A., Campos, I., MacLachlan, J., Mueller, U., Kim, D., Trillini, M., Eshrati, B., Williams, H. C., Shibuya, K., Dandona, R., Murthy, K., Cowie, B., Amare, A. T., Antonio, C. A., Castañeda-Orjuela, C., van Gool, C. H., Violante, F., Oh, I.-H., Deribe, K., Soreide, K., Knibbs, L., Kereselidze, M., Green, M., Cardenas, R., Roy, N., Tillmann, T., Li, Y., Krueger, H., Monasta, L., Dey, S., Sheikhbahaei, S., Hafezi-Nejad, N., Kumar, G. A., Sreeramareddy, C. T., Dandona, L., Wang, H., Vollset, S. E., Mokdad, A., Salomon, J. A., Lozano, R., Vos, T., Forouzanfar, M., Lopez, A., Murray, C., & Naghavi, M.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2015-07-01
- Volume
- 1
- Issue
- 4
- Pages
- 505
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2148287035
- Cited by
- 2,707
- References
- 51
- FWCI
- 149.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.